Diminished ovarian reserve
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Female patients aged between 20 and 40 years old; (2) Conforming to the diagnostic criteria of Western and Chinese medicine for ovarian reserve dysfunction; (3) Those who have not received hormone therapy or other related treatments for the disease in the past three months; (4) Those who voluntarily sign an informed consent form voluntarily cooperate with treatment and have strong compliance.
Exclusion criteria
Exclusion criteria: (1) Primary or secondary amenorrhea or genital malformations caused by congenital reproductive organ developmental abnormalities or acquired organic lesions; (2) Patients with primary diseases such as cardiovascular and cerebrovascular diseases, Endocrine system diseases, hematopoietic system diseases and mental diseases such as anxiety and depression; (3) Known or suspected precancerous lesions or malignant tumors affected by sex hormones; (4) Suffering from severe liver, kidney, heart, and brain diseases; (5) Known or suspected pregnancy; (6) Participants in other clinical trials; (7) Patients who receive treatment with other exogenous hormones within 3 months; (8) Patients with a family history of ovarian dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FSH;AMH; | — |
Secondary
| Measure | Time frame |
|---|---|
| E2;LH; | — |
Countries
China
Contacts
Dongguan Maternal and Child Health Care Hospital